share_log

广生堂(300436.SZ)：预计2023年净亏损2.6亿元-2.98亿元

Guangshengtang (300436.SZ): Expected net loss of 260 million yuan to 298 million yuan in 2023

Gelonghui Finance ·  Jan 30 21:12

On January 30, Gelonghui | Guangshengtang (300436.SZ) announced that it expects net loss of 260 million yuan to 298 million yuan in 2023, deducting non-net loss of 248 million yuan to 286 million yuan, and operating income of 41 million yuan to 430 million yuan.

During the reporting period, the company continued to invest in innovative drug research and development. The innovative drug GST-HG131 entered clinical phase II, GST-HG141 completed clinical phase II enrollment, and the anti-COVID-19 drug Taizhong was approved, achieving “zero breakthroughs” in the launch of innovative drugs. The company invested 187 million yuan in R&D in 2022, and about 284 million yuan in R&D for the full year of 2023, which is expected to increase by about 52% over the previous year.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment